Bioasis and WuXi Biologics Announce Initial Strategic Collaboration for the Development and Manufacturing of xB3-001, the Company’s Lead Investigational Candidate to Treat Brain Cancer

(Source: Taiwan News) For more information on WuXi Biologics, please visit www.wuxibiologics.com. … xB 3, a proprietary platform technology for the delivery of therapeutics across the ..